In non-diabetic obese adults, liraglutide (3.0 mg) resulted in an average weight loss of approximately 3.4 kg more than placebo over 56 weeks
The mechanistic concern voiced by dermatologists is not usually that the compound initiates melanoma from nothing, but that stimulating melanocytes may accelerate progression of pre-existing dysplastic or early-mutated lesions toward malignancy
Yes, when used as prescribed and medically supervised
The geneticist that Maggie saw in Mexico City said that there is great excitement among the EDS community as a big announcement is expected at the upcoming International Scientific Symposium on the Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders
National Institute for Health and Care Excellence (NICE) criteria for initiation of GLP-1 and GIP analogues is as follows: if triple therapy with metformin and two other oral drugs is not effective, not tolerated or contraindicated, consider triple therapy by switching one drug for a GLP-1 analogues for adults with T2DM who have a body mass index (BMI) of 35kg/m 2 or higher[15]
If the question is which has established clinical availability, approved GLP-1 receptor agonists clearly have the advantage